Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Net Margin (2020 - 2022)

RAPT Therapeutics' Net Margin history spans 3 years, with the latest figure at 2134.2% for Q2 2022.

  • For Q2 2022, Net Margin fell 28034.0% year-over-year to 2134.2%; the TTM value through Mar 2023 reached 10900.68%, down 871234.0%, while the annual FY2022 figure was 5618.53%, 387544.0% down from the prior year.
  • Net Margin for Q2 2022 was 2134.2% at RAPT Therapeutics, up from 3241.34% in the prior quarter.
  • Across five years, Net Margin topped out at 829.03% in Q4 2020 and bottomed at 3241.34% in Q1 2022.
  • The 3-year median for Net Margin is 1629.55% (2021), against an average of 1668.25%.
  • The largest annual shift saw Net Margin skyrocketed 5385bps in 2021 before it tumbled -188995bps in 2022.
  • A 3-year view of Net Margin shows it stood at 829.03% in 2020, then plummeted by -142bps to 2009.13% in 2021, then fell by -6bps to 2134.2% in 2022.
  • Per Business Quant, the three most recent readings for RAPT's Net Margin are 2134.2% (Q2 2022), 3241.34% (Q1 2022), and 2009.13% (Q4 2021).